StemCells Gets a 'Buy' Rating

StemCells (STEM) got a buy recommendation. "Maxim Group initiated coverage of this company with a rating of Buy and a price target of $2.50." STEM closed yesterday (02012.08.22) at $1.46. STEM hit an intra-day high of $2.31 just one month ago on 02012.07.25. Today, STEM hit an intra-day high of $1.75 on heavy volume. With 30 minutes left in trading it's at $1.66, up almost 14%.